Insider · CIK 0001543031

Quimi Daphne

CIK 0001543031 Name as filed on the most recent filing

Filed as Quimi Daphne (22)

28 transaction lines · from 22 filings · filed 2014-10-01 to 2024-09-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

28 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-09-12 P, Open-market purchase Century Therapeutics, Inc.IPSC 7,657, acquired Open Form 4 filing 0001062993-24-016641
2024-05-15 P, Open-market purchase Amylyx Pharmaceuticals, Inc.AMLX 4,252, acquired Open Form 4 filing 0000950170-24-061294
2024-05-14 P, Open-market purchase Amylyx Pharmaceuticals, Inc.AMLX 5,184, acquired Open Form 4 filing 0000950170-24-061294
2023-01-18 S, Open-market sale Amicus Therapeutics, Inc.FOLD 89,999, disposed Open Form 4 filing 0001209191-23-004080
2023-01-17 S, Open-market sale Amicus Therapeutics, Inc.FOLD 62,445, disposed Open Form 4 filing 0001209191-23-004080
2022-09-01 S, Open-market sale Amicus Therapeutics, Inc.FOLD 49,621, disposed Open Form 4 filing 0001209191-22-048797
2022-08-05 S, Open-market sale Amicus Therapeutics, Inc.FOLD 69,576, disposed Open Form 4 filing 0001209191-22-045060
2022-06-17 S, Open-market sale Amicus Therapeutics, Inc.FOLD 39,564, disposed Open Form 4 filing 0001209191-22-038365
2020-12-21 S, Open-market sale Amicus Therapeutics, Inc.FOLD 120,474, disposed Open Form 4 filing 0001209191-20-065059
2020-10-01 S, Open-market sale Amicus Therapeutics, Inc.FOLD 70,099, disposed Open Form 4 filing 0001209191-20-053728
2020-07-01 S, Open-market sale Amicus Therapeutics, Inc.FOLD 106,326, disposed Open Form 4 filing 0001104659-20-081467
2020-01-09 S, Open-market sale Amicus Therapeutics, Inc.FOLD 148,952, disposed Open Form 4 filing 0001209191-20-003091
2018-03-09 S, Open-market sale Amicus Therapeutics IncFOLD 131,250, disposed Open Form 4 filing 0001209191-18-018938
2018-03-01 S, Open-market sale Amicus Therapeutics IncFOLD 114,537, disposed Open Form 4 filing 0001209191-18-016786
2018-01-02 S, Open-market sale Amicus Therapeutics IncFOLD 117,723, disposed Open Form 4 filing 0001209191-18-002051
2017-10-12 S, Open-market sale Amicus Therapeutics IncFOLD 99,740, disposed Open Form 4 filing 0001209191-17-057053
2016-11-09 S, Open-market sale Amicus Therapeutics IncFOLD 2 lines 68,368, disposed Open Form 4 filing 0001209191-16-149319
2015-10-01 S, Open-market sale Amicus Therapeutics IncFOLD 147,761, disposed Open Form 4 filing 0001209191-15-074167
2015-09-14 S, Open-market sale Amicus Therapeutics IncFOLD 45,200, disposed Open Form 4 filing 0001209191-15-070953
2015-07-01 S, Open-market sale Amicus Therapeutics IncFOLD 36,350, disposed Open Form 4 filing 0001209191-15-058122
2015-05-11 S, Open-market sale Amicus Therapeutics IncFOLD 81,306, disposed Open Form 4 filing 0001209191-15-042025
2014-11-25 S, Open-market sale Amicus Therapeutics IncFOLD 28,000, disposed Open Form 4 filing 0001209191-14-071258
2014-11-25 P, Open-market purchase Amicus Therapeutics IncFOLD 28,000, acquired Open Form 4 filing 0001209191-14-071258
2014-10-03 S, Open-market sale Amicus Therapeutics IncFOLD 47,684, disposed Open Form 4 filing 0001209191-14-062135
2014-10-03 P, Open-market purchase Amicus Therapeutics IncFOLD 47,684, acquired Open Form 4 filing 0001209191-14-062135
2014-09-29 S, Open-market sale Amicus Therapeutics IncFOLD 65,465, disposed Open Form 4 filing 0001209191-14-060721
2014-09-29 P, Open-market purchase Amicus Therapeutics IncFOLD 65,465, acquired Open Form 4 filing 0001209191-14-060721

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 22
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Quimi Daphne, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001543031

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.